425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. are proceeding with a proposed business combination, as detailed in a recent communication reposted by Strive's Board Member.

Summary

• Strive, Inc. and Semler Scientific, Inc. are engaged in a proposed business combination.
• The communication regarding this transaction was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on September 25, 2025.
• The filing includes a cautionary statement regarding forward-looking statements pertinent to the proposed transaction.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will encompass an Information Statement/Proxy Statement/Prospectus.
• Stockholders of Semler Scientific will be required to approve the proposed transaction.
• Details concerning participants in the solicitation of proxies, including directors and executive officers of both companies, will be provided in the forthcoming Information Statement/Proxy Statement/Prospectus.

Sentiment

Score: 6

Explanation: The filing announces a significant corporate event (a proposed merger), which is generally a positive strategic development. However, it is primarily a legal disclosure heavily weighted with cautionary statements and extensive risk factors, which balances the overall sentiment to a neutral-to-slightly-positive outlook, typical for such procedural merger announcements.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• Anticipated financial benefits are projected for the combined entity.
• The companies anticipate the successful integration of their respective businesses.

Negatives

• Integration of the two companies may prove more difficult, time-consuming, or costly than initially expected.
• The proposed transaction could be more expensive or take longer to complete than anticipated due to unforeseen factors.
• Management's attention may be diverted from ongoing business operations and other opportunities.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will cause dilution for existing shareholders.
• There is a potential for adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price may occur before the closing of the transaction.

Risks

• The occurrence of any event, change, or other circumstances could lead to the termination of the merger agreement by either Strive or Semler Scientific.
• The proposed transaction may not close as expected or at all if the conditions to closing are not met or satisfied in a timely manner.
• The outcome of any legal proceedings that may be initiated against Strive, Semler Scientific, or the combined company could be adverse.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all, partly due to risks associated with Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and changes in laws and regulations could negatively impact the transaction.
• The integration process could be more challenging, time-consuming, or costly than projected.
• The transaction may incur higher expenses or take longer to complete than anticipated.
• Management's focus may be diverted from core business operations.
• Dilution of Strive's Class A common stock will occur due to the issuance of new shares.
• Potential adverse reactions from customers or disruptions to business and employee relationships may arise.
• Fluctuations in Strive's or Semler Scientific's share price could occur prior to closing.
• Other unknown or unpredictable factors could materially harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

Strive and Semler Scientific anticipate realizing strategic and financial benefits from the proposed business combination, including successful integration and a positive impact on future financial performance. However, these forward-looking statements are subject to inherent risks and uncertainties that could cause actual results to differ materially.

Management Comments

• Pierre Rochard, Board Member of Strive, Inc., reposted the communication on X.com on September 25, 2025, in connection with the proposed business combination.

Industry Context

The filing highlights the potential impact of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' on the combined company's future performance. This indicates a strategic focus on digital asset management, aligning with a growing trend among certain companies to incorporate cryptocurrencies into their treasury operations or broader business models.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company is identified as a risk factor for the proposed transaction.

Related Party Transactions

• Information regarding Semler Scientific's transactions with related persons is available in its definitive proxy statement for its 2025 Annual Meeting of Stockholders, though no specific transactions are detailed in this filing.

Stakeholder Impact

• Shareholders of Strive face potential dilution due to the issuance of additional Class A common stock.
• Customers of both Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Employee relationships and business operations could be subject to changes or disruptions as a result of the merger.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be distributed to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to provide their approval for the proposed transaction.

Key Dates

Keywords

Strive, Semler Scientific, merger, business combination, SEC filing, Form 425, forward-looking statements, Bitcoin treasury, digital assets, proxy statement, S-4 filing, corporate governance